Literature DB >> 11579258

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

O Gallego1, L Ruiz, A Vallejo, E Ferrer, A Rubio, B Clotet, M Leal, V Soriano.   

Abstract

Genotypic resistance to antiretroviral drugs was examined in 684 individuals attending 18 outpatient clinics distributed across Spain in June 2000. Compared with similar surveys conducted before 1998, the prevalence of resistance to nucleosides has declined significantly among naive chronic HIV carriers. In contrast, resistance among pre-treated patients has increased; resistance to all three drug families having been recognized in nearly a quarter of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579258     DOI: 10.1097/00002030-200109280-00025

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates.

Authors:  J García-Guerrero; P Sáiz de la Hoya; J Portilla; A Marco; J Sánchez-Payá; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

2.  Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.

Authors:  Oscar Gallego; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.

Authors:  Lily W Y Tam; Celia K S Chui; Chanson J Brumme; David R Bangsberg; Julio S G Montaner; Robert S Hogg; P Richard Harrigan
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

4.  Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain.

Authors:  Oscar Gallego; Lidia Ruíz; Alex Vallejo; Bonaventura Clotet; Manuel Leal; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.